Navigation Links
New Study: Improved Immune System with Gene-Eden, a Natural Antiviral Supplement that Targets Chronic Viruses

New study revealed that the antiviral supplement Gene-Eden caused a complete recovery of the immune system and an amazing 34% reduction in tumor size in a patient with pancreatic cancer treated with second-line chemotherapy that is used for relieving symptoms rather than shrinking tumor.

(PRWEB) March 1, 2010 -- New study revealed that treatment with the natural antiviral supplement Gene-Eden caused a complete recovery of the immune system and an amazing 34% reduction in tumor size in a patient with pancreatic cancer. The study, which was conducted at the Center for the Biology of Chronic Disease by Hanan Polansky and Ido Dafni, was recently published in Acta Oncologica, a leading scientific journal in clinical oncology and related disciplines, and the official journal of the five Nordic oncological societies.

Pancreatic cancer is one of the most aggressive types of cancer and is very resistant to medical treatment. In United States alone, physicians diagnose more than 40,000 new cases each year, and more than 35,000 die from it annually. The common treatments include surgical removal of the tumor (only for localized disease), chemotherapy, and radiation therapy. The tragedy is that these treatments have a limited impact on the progression of the disease, and as a result, less than 5 percent of the patients are still alive five years after diagnosis. Complete remission is very rare.

The patient in the study was a 61 years old female, who was diagnosed with an inoperable pancreatic carcinoma. After two months of chemotherapy, which had no effect on the tumor growth, yet caused a sharp decline the number of immune cells, the treatment was replaced with a second-line chemotherapy, which is used for relieving symptoms rather than shrinking tumor. In addition, the patient was treated with Gene-Eden. Five weeks later, to the great surprise of the medical staff, a CT scan and some blood tests showed that the tumor shrank by 34%, and that the number of immune cells returned normal levels!

Gene-Eden is a broad range antiviral supplement that targets viruses during their latent or chronic phase. The development of Gene-Eden was inspired by Hanan Polansky’s discovery of the Starved Gene phenomenon. According to Polansky, common viruses, such as the Hepatitis Virus, Epstein Barr Virus (EBV), Cytomegalovirus (CMV), and Herpes Simplex Virus (HSV), are genetic parasites. After they plant themselves in the nucleus, they “steal” needed resourced from the human genes. The starved human genes produce less proteins, such as Retinoblastoma (Rb) and BRCA1, and the cell can no longer control its rate of replication. The result is excessive cell replication and development of tumors.

For a more detailed explanation of the Starved Gene discovery, specifically formulated for the general public, see

According to the Starved Gene phenomenon, chronic viruses can cause many major diseases, and specifically pancreatic cancer, and an antiviral treatment that targets chronic viruses should be effective in treating the disease. According to the authors of the study, the results suggest that by targeting the chronic viruses in the patient’s body, Gene-Eden contributed to the surprising improvement in the patient’s condition.

For more information on Gene-Eden, visit Gene-Eden is available on

Study: “Gene-Eden, a broad range, natural antiviral supplement, may shrink tumors and strengthen the immune system” Hanan Polansky, Ido Dafni. Acta Oncologica; Posted online on 8 Jan 2010.

# # #

Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. U of M study: Early treatment can reverse heart damage
2. New study: Pine bark reduces perimenopausal symptoms
3. U of M study: Health food supplement may curb addiction of pathological gamblers
4. New study: Pine bark extract reduces ADHD symptoms in children
5. Kaiser Permanente study: Alcohol amount, not type -- wine, beer, liquor -- triggers breast cancer
6. UGA study: Youth exposed to smokeless tobacco ads despite settlement
7. New National Medicaid Study: Minnesota Under Funds Seniors Nursing Home Care $167 Million Annually
8. Study: Modafinil is effective in treating excessive sleepiness
9. Breaking Study: Masimo Pleth Variability Index (PVI) Shown Effective in Noninvasive Detection of Changes in Ventricular Preload and Fluid Volume
10. New study: pine bark extract boosts nitric oxide production
11. Study: HPV test beats Pap in detecting cervical cancer
Post Your Comments:
Related Image:
New Study: Improved Immune System with Gene-Eden, a Natural Antiviral Supplement that Targets Chronic Viruses 
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as ... City area —Johnson is one of the first doctors to perform the treatment. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from reveals that ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... To deal with these feelings, many turn to unhealthy avenues, such as drug or ... Center of Marne, Michigan, has released tools for healthy coping following a traumatic event. ...
(Date:6/24/2016)... ... ... was in a crisis. Her son James, eight, was out of control. Prone to extreme ... “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was ... other children and say he was going to kill them. If we were driving ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
(Date:6/24/2016)... 24, 2016 Research and ... "Structural Electronics 2015-2025: Applications, Technologies, Forecasts" report ... In-Mold Electronics, Smart Skin, Structural Health Monitoring, ... Structural electronics involves electronic and/or electrical components ... replacing dumb structures such as vehicle bodies or ...
(Date:6/24/2016)... ANDOVER, Mass. and SAN CLEMENTE, Calif. ... California -based mobile pulmonary function testing company, is now ... portable PFT devices developed by ndd Medical Technologies , Inc. ... PFT testing done in hospital-based labs.  Thanks to ndd,s EasyOne PRO ... CA , can get any needed testing done in the ...
Breaking Medicine Technology: